iRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer Says
iRhythm (IRTC) could benefit from stronger sales growth, wider access to the cardiac monitoring mark
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
